A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, ...

The findings, published in The Lancet Oncology, might significantly minimize the number of unnecessary procedures and ensure ...

UCLA Health researchers unveiled a novel non-invasive imaging technique that accurately detects clear-cell renal cell ...

A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

The healthcare brand offers paid research opportunities for patients and family caregivers in the US New Hope, Pennsylvania-- ...

Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic ...

No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.

Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco (AIFA) has approved a new Phase 1 ...

For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, ...